Jasmin McVeigh Founder of Bodology Jasmin McVeigh founded Bodology after a personal health breakthrough revealed the central role of metabolic health in conditions like PCOS, Hashimoto's, and PMDD
Refyne is a bit softer, and so it creates a more natural result when placed superficially, as compared to Defyne
Expert recommendations instead suggest that if a whole-body DXA is performed and indicates low bone density, it should be followed up with a standard DXA at the clinically relevant sites
This observation is consistent with the relatively minimal effect of BETP on signaling of the potent GLP-1R endogenous agonist GLP-1, compared to the weaker agonist GLP-1(9-36)amide, whose effects are potentiated by BETP ( 21 )
The durable anti-tumor effects observed even after retatrutide withdrawal suggest immune system changes may be as important as direct metabolic effects making the tumor microenvironment and immunological panels critical readouts in any study design
Who is at higher risk of dizziness on GLP-1 therapy